Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 18, 2017 - Issue 13
Submit an article Journal homepage
565
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluation

Evaluation of brivaracetam: a new drug to treat epilepsy

Jasmina R. MilovanovićFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaView further author information
,
Slobodan M. JankovićFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1519-8828View further author information
ORCID Icon,
Ana PejčićFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaORCID Iconhttps://orcid.org/0000-0003-1741-0025View further author information
ORCID Icon,
Miloš MilosavljevićFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaView further author information
,
Valentina OpančinaFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaView further author information
,
Vesela RadonjićFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaView further author information
,
Zoran ProtrkaFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaView further author information
&
Marina KostićFaculty of Medical Sciences, Department of Pharmacology and Toxicology, University of Kragujevac, Kragujevac, SerbiaView further author information
 show all
Pages 1381-1389 | Received 19 Jul 2017, Accepted 19 Jul 2017, Published online: 28 Jul 2017

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Eleonora Tulli, Giuseppe Di Cara, Giulia Iapadre, Pasquale Striano & Alberto Verrotti. (2021) An update on brivaracetam for the treatment of pediatric partial epilepsy. Expert Opinion on Pharmacotherapy 22:11, pages 1387-1395.
Read now
Stefano de Biase, Gian Luigi Gigli & Mariarosaria Valente. (2020) Brivaracetam for the treatment of focal-onset seizures: pharmacokinetic and pharmacodynamic evaluations. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 853-863.
Read now

Articles from other publishers (12)

Hongyi Yang, Leting Yang, Xiaofang Zhong, Xuehua Jiang, Liang Zheng & Ling Wang. (2022) Physiologically based pharmacokinetic modeling of brivaracetam and its interactions with rifampin based on CYP2C19 phenotypes. European Journal of Pharmaceutical Sciences 177, pages 106258.
Crossref
Katharina Kneppe & David Czell. (2022) Brivaracetam – eine gute Alternative in der akuten Behandlung der Trigeminusneuralgie. Praxis 111:1, pages 21-25.
Crossref
Te-Yu Hung, Sheng-Nan Wu & Chin-Wei Huang. (2021) The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability. Biomedicines 9:4, pages 369.
Crossref
Joanna Jędrzejczak, Beata Majkowska-Zwolińska, Anna Chudzicka-Bator, Iwona Żerda, Magdalena Władysiuk & Brian Godman. (2021) Economic and social cost of epilepsy in Poland: 5-year analysis. The European Journal of Health Economics 22:3, pages 485-497.
Crossref
Tokareva N.G. & Ignatieva O.I.. (2021) FEATURES OF MODERN PHARMACOTHERAPY OF EPILEPTIC STATUS. "Medical & pharmaceutical journal "Pulse", pages 31-38.
Crossref
Katharina Kneppe & David Czell. (2020) Brivaracetam – eine gute Alternative zur Behandlung von MuskelkrämpfenBrivaracetam—A good alternative for the treatment of muscle cramps. Der Nervenarzt 91:12, pages 1130-1133.
Crossref
Andreea Nissenkorn, Michal Tzadok, Omer Bar-Yosef & Bruria Ben-Zeev. (2019) Treatment with brivaracetam in children – The experience of a pediatric epilepsy center. Epilepsy & Behavior 101, pages 106541.
Crossref
Joel M Oster. (2019) Brivaracetam: a newly approved medication for epilepsy. Future Neurology 14:3, pages FNL23.
Crossref
Shanshan Yu, Peiyuan Yao, Jinlong Li, Jinhui Feng, Qiaqing Wu & Dunming Zhu. (2019) Improving the catalytic efficiency and stereoselectivity of a nitrilase from Synechocystis sp. PCC6803 by semi-rational engineering en route to chiral γ-amino acids . Catalysis Science & Technology 9:6, pages 1504-1510.
Crossref
Bernhard J. Steinhoff & Anke M. Staack. (2019) Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience. Therapeutic Advances in Neurological Disorders 12, pages 175628641987351.
Crossref
Samuele Ciceri, Paride Grisenti, Shahrzad Reza Elahi & Patrizia Ferraboschi. (2018) A New Chemoenzymatic Synthesis of the Chiral Key Intermediate of the Antiepileptic Brivaracetam. Molecules 23:9, pages 2206.
Crossref
Martin Holtkamp. (2018) Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults. Drugs 78:3, pages 307-326.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.